Andrew Gentles

Assistant Professor (Research) of Pathology, of Medicine (BMIR) and, by courtesy, of Biomedical Data Science

Bio

BSc (Hons) Physics, University of Manchester, UK
PhD Theoretical particle physics, University of Southampton, UK

Stanford Advisees

Doctoral Dissertation Reader (AC)
Brooks Benard, Vandon Duong, Victoria Hernandez, Irene Li
Doctoral Dissertation Co-Advisor (AC)
Asiri Ediriwickrema

Graduate and Fellowship Programs

Bioengineering (Phd Program)
Biomedical Informatics (Masters Program)
Biomedical Informatics (Phd Program)
Cancer Biology (Phd Program)
Immunology (Phd Program)
Medicine (Masters Program)
Microbiology and Immunology (Phd Program)
Neurosciences (Phd Program)

All Publications

Profiles With Related Publications

close
Ash A. Alizadeh, MD/PhD

Moghadam Family Professor
Clinical Focus
Cancer > Lymphoma, Lymphoma, B-Cell Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia, Burkitt Lymphoma, Follicular Lymphoma, Diffuse Large-Cell Lymphomas, Leukemia, Hairy Cell, Lymphoma, B-Cell, Marginal Zone, Hodgkin Disease, Medical Oncology
Research Interests
My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.

Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.

375 Total Publications
close
Gill Bejerano

Professor of Developmental Biology, of Computer Science, of Pediatrics (Genetics) and of Biomedical Data Science
Research Interests
1. Automating monogenic patient diagnosis.
2. The genomic signatures of independent divergent and convergent trait evolution in mammals.
3. The logic of human gene regulation.
4. The reasons for sequence ultraconservation.
5. Cryptogenomics to bridge medical silos.
6. Cryptogenetics to debate social injustice.
7. Managing patient risk using machine learning.
8. Understanding the flow of money in the US healthcare system.

121 Total Publications
close
Patrick O. Brown

Professor of Biochemistry, Emeritus
Research Interests
Dr. Brown, currently an emeritus professor, is CEO and founder of Impossible Foods, a company dedicated to replacing the world's most destructive technology - the use of animals to transform plant biomass into meat, fish and dairy foods - by developing a new and better way to produce the world's most delicious, nutritious and affordable meats, fish and dairy foods directly from plants. Visit impossiblefoods.com for more information.

319 Total Publications
close
Mike Cherry

Professor (Research) of Genetics
Research Interests
My research involves identifying, validating and integrating scientific facts into encyclopedic databases essential for research and scientific education. Published results of scientific experimentation are a foundation of our understanding of the natural world and provide motivation for new experiments. The combination of in-depth understanding reported in the literature with computational analyses is an essential ingredient of modern biological research.

144 Total Publications
close
Michael F. Clarke, M.D.

Karel H. and Avice N. Beekhuis Professor of Cancer Biology
Research Interests
Dr. Clarke maintains a laboratory focused on two areas of research: i) the control of self-renewal of normal stem cells and diseases such as cancer and hereditary diseases; and ii) the identification and characterization of cancer stem cells. His laboratory is investigating how perturbations of stem cell regulatory machinery contributes to human disease. In particular, the laboratory is investigating epigenetic regulators of self renewal, the process by which stem cells regenerate themselves.

180 Total Publications
close
Dean W. Felsher

Professor of Medicine (Oncology) and of Pathology
Research Interests
My laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.

214 Total Publications
close
Jiaying Feng

Program Manager, Graduate School of Business - Executive Education

8 Total Publications
close
Olivier Gevaert

Associate Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science
Research Interests
My lab focuses on biomedical data fusion: the development of machine learning methods for biomedical decision support using multi-scale biomedical data. We primarily use methods based on regularized linear regression to accomplish this. We primarily focus on applications in oncology and neuroscience.

159 Total Publications
close
Kathleen Houlahan

Postdoctoral Scholar, Stanford Cancer Center

27 Total Publications
close
Siddhartha Jaiswal

Assistant Professor of Pathology
Clinical Focus
Transfusion Medicine, Genomics and Molecular Pathology, Clinical Pathology
Research Interests
We identified a common disorder of aging called clonal hematopoiesis of indeterminate potential (CHIP). CHIP occurs due to certain somatic mutations in blood stem cells and represents a precursor state for blood cancer, but is also associated with increased risk of cardiovascular disease and death. We hope to understand more about the biology and clinical implications of CHIP using human and model system studies.

49 Total Publications
close
Ronald Levy, MD

Robert K. and Helen K. Summy Professor in the School of Medicine
Clinical Focus
Cancer > Lymphoma, Lymphoma , Non-Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma - Medical Oncology, Burkitt's Lymphoma, Burkitt's Lymphoma - Medical Oncology, Hodgkin's Disease, Hodgkin's Disease - Medical Oncology, Burkitt's Lymphoma - Hematology, Hodgkin's Disease - Hematology, Oncology (Cancer), Non-Hodgkin's Lymphoma - Hematology, Medical Oncology
Research Interests
Clinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer.

411 Total Publications
close
Ravi Majeti MD, PhD

Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine, RZ Cao Professor and Professor of Medicine (Hematology)
Clinical Focus
Hematology
Research Interests
The Majeti lab focuses on the molecular/genomic characterization and therapeutic targeting of leukemia stem cells in human hematologic malignancies, particularly acute myeloid leukemia (AML). Our lab uses experimental hematology methods, stem cell assays, genome editing, and bioinformatics to define and investigate drivers of leukemia stem cell behavior. As part of these studies, we have led the development and application of robust xenotransplantation assays for human hematopoietic cells.

171 Total Publications